Skip to main content

Table 1 MCL patients’ characteristics and clinical-pathologic features for the whole cohort and different racial groups

From: Racial differences in mantle cell lymphoma in the United States

  Total (n = 2958) Non-Hispanic white (n = 2620) Hispanic white (n = 109) Black (n = 121) Asian/PI (n = 108) P
Gender       0.043
Male 1989 (67.2) 1775 (67.7) 77 (70.6) 68 (56.2) 69 (63.9)  
Female 969 (32.8) 845 (32.3) 32 (29.4) 53 (43.8) 39 (36.1)  
Marital Status       <0.001
Single 243 (8.7) 195 (7.9) 20 (20.8) 21 (18.8) 7 (6.8)  
Married 1905 (68.4) 1721 (69.6) 59 (61.5) 48 (42.9) 77 (74.8)  
Separated/divorced/widowed 636 (22.8) 557 (22.5) 17 (17.7) 43 (38.4) 19 (18.4)  
Age at diagnosis 67.8 ± 12.3 68.2 ± 12.1 64.3 ± 12.7 62.8 ± 13.7 67.0 ± 12.1 <0.001
Stage       0.029
Stage I 396 (14.1) 338 (13.6) 20 (20.2) 18 (15.8) 20 (18.7)  
Stage II 251 (8.9) 219 (8.8) 8 (8.1) 9 (7.9) 15 (14.0)  
Stage III 411 (14.7) 357 (14.4) 17 (17.2) 26 (22.8) 11 (10.3)  
Stage IV 1747 (62.3) 1571 (63.2) 54 (54.5) 61 (53.5) 61 (57.0)  
B symptoms       0.108
No 1070 (36.2) 949 (36.2) 47 (43.1) 36 (29.8) 38 (35.2)  
Yes 596 (20.1) 513 (19.6) 23 (21.1) 35 (28.9) 25 (23.1)  
Unknown 1292 (43.7) 1158 (44.2) 39 (35.8) 50 (41.3) 45 (41.7)  
Extranodal involvement       <0.001
No 2478 (83.8) 2206 (84.2) 93 (85.3) 106 (87.6) 73 (67.6)  
Yes 480 (16.2) 414 (15.8) 16 (14.7) 15 (12.4) 35 (32.4)  
Survival time (month) (Median ± SD) 46.0 ± 1.8 46.0 ± 1.9 57.0 ± 13.5 39.0 ± 7.9 46.0 ± 6.8 0.735
  1. Cancers diagnosed between 1992 and 2009 in the SEER 9 database. For a continuous variable, mean ± standard deviation, and for a categorical variable, count (percentage).